Bliss GVS Pharma fundamental analysis

BLISSGVS

269.75

4.35 (-1.59%)
Last updated on 5 May, 2026 | 15:42 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bliss GVS Pharma Fundamentals

P/E Ratio

26.61

P/B Ratio

2.51

Div. Yield

0.18

Sector P/E

66.8

Sector P/B

3.52

Sec. Div. Yield

0.56

Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 26.61, compared to the sector average of 66.8. Its P/B Ratio stands at 2.51, while the sector’s is 3.52. In terms of returns, the stock offers a Dividend Yield of 0.18%, which is than the sector’s 0.56%.

Bliss GVS Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Average

On its scorecard, Bliss GVS Pharma reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost